Ernst Westman new Chairman of the Board

Nov 11, 2017

The board of directors has elected Mr. Ernst Westman as new Chairman of the Board of Capitainer AB. Mr. Westman has been President and CEO of the listed blood diagnostics Boule Diagnostics AB (publ) between 1994 to 2017 and now takes over the leadership in Capitainer AB as the company is preparing market entry.

“We are delighted to have Ernst as Chairman for Capitainer. His experience in the blood diagnostic industry and proven track record in transforming Boule into billion-SEK company with world-wide sales is exactly the kind of competence Capitainer needs”, says former Chairman and co-founder Dr. Niclas Roxhed.

Ernst Westman new Chairman of the Board

Read more news

Meet us at IATDMCT Congress in Brisbane 16-19/9

    Capitainer participates in (IATDMCT) Congress 2018, 16–19 September 2018 in Brisbane, Australia The 16th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2018) will be held from Sunday 16th to Wednesday 19th September, 2018 in...

Meet us at AACC Annual Scientific Meeting

    Capitainer participates in AACC Annual Scientific Meeting July29-August 2, 2018 The 70th AACC Annual Scientific Meeting & Clinical Lab Expo is the largest global scientific conference and tradeshow in the field of laboratory medicine. This is part of our strategy...

Capitainer participates and sponsors CPSA Europe 2018

    Capitainer participates in, and sponsors, the inaugural European symposium on Clinical & Pharmaceutical Solutions through Analysis  -CPSA Europe 2018, in Cambridge, UK. This is part of our strategy to promote the Capitainer concept to the most important audiences....

Capitainer invited speaker at PRINSE’18

    Capitainer was invited speaker in the diagnostics session at PRINSE’18 (the 5th Printed Intelligense Industry Seminar) this year focusing on ”Manufacturing Solutions for Customer Needs and Vision to the Future”, Jan 31- Feb 1, 2018, in Oulu, Finland. The event...

Ta blodprovet själv, KTH magazine

Hjärtpatienten Sigvard sitter hemma i köket och förbereder ett blodprov på sig själv. Efter hjärtattacken för ett halvår sedan behandlas han med den blodförtunnande medicinen Waran för att minska risken för återfall. Ett problem med Waran är att doseringen är väldigt...

Capitainer Featured on KTH Home Page

Capitainer technology is highlighted as a news article on KTH’s first page. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam for further...

Capitainer Selected Best Start-Up

Capitainer was selected best Start-Up at the Nordic Pitch Night event Aug 25 in Silicon Valley, USA Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam for...

Nordic Life Science Days, Sept. 14-15 in Stockholm

Capitainer has been selected to exhibiting at the Nordic Life Science days Sept. 14-15 in Stockholm. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam for...

AACC Annual Scientific Meeting & Clinical Lab Expo

Capitainer is presenting their technology at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo Aug 1-4, in Philadelphia, USA. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to...

Brighter Startup Program

Capitainer is attending the Brighter Startup Program, a one week program for Swedish entrepreneurs located in Silicon Valley’s unique and leading innovation and entrepreneurship ecosystem. Read more news Get In Touch   We are currently seeking funding to reach set-up...

Capitainer Exhibits at STING-day

Capitainer is selected as one of few KTH-start-ups to exhibit at the prestigious STING-day on May 28, an investor event gathering Stockholm’s most promising tech start-ups connecting then to VC’s and investors from around the world. Read more news Get In Touch   We...

Clinical Chemistry Meeting in Malmö

Capitainer is presenting at the Swedish Clinical Chemistry spring meeting in Malmö May 11-13, Sweden. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam for...

KTH’s President’s innovation event

Capitainer is selected to present during KTH’s President’s innovation event. Read more news Get In Touch   We are currently seeking funding to reach set-up milestones. We welcome investors interested to contact our CEO – Peter Brautigam for further...

Capitainer Awarded 2 MSEK

Capitainer is awarded 2 MSEK in seed funding from the Swedish Innovation Agency VINNOVA in the competitive ViNNVerifiering program, a program in designed to promote the best academic start-up cases. Read more news Get In Touch   We are currently seeking funding to...

Get in touch with us